APA

Burstein E. S., Ma J., Wong S., Gao Y., Pham E., Knapp A. E., Nash N. R., Olsson R., Davis R. E., Hacksell U., Weiner D. M. & Brann M. R. (20060123). Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. : The Journal of pharmacology and experimental therapeutics.

Chicago

Burstein E S, Ma J, Wong S, Gao Y, Pham E, Knapp A E, Nash N R, Olsson R, Davis R E, Hacksell U, Weiner D M and Brann M R. 20060123. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. : The Journal of pharmacology and experimental therapeutics.

Harvard

Burstein E. S., Ma J., Wong S., Gao Y., Pham E., Knapp A. E., Nash N. R., Olsson R., Davis R. E., Hacksell U., Weiner D. M. and Brann M. R. (20060123). Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. : The Journal of pharmacology and experimental therapeutics.

MLA

Burstein E S, Ma J, Wong S, Gao Y, Pham E, Knapp A E, Nash N R, Olsson R, Davis R E, Hacksell U, Weiner D M and Brann M R. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. : The Journal of pharmacology and experimental therapeutics. 20060123.